GFAP and central nervous system cancer: These plasmids have been previously used to overexpress the GGGGCC-motif in vitro in U251 glial fibrillary acidic protein–positive glioma cells (45) or in vivo in mouse brain via intraventricular adeno-associated virus (AAV)–mediated delivery (44).